摘要
宫颈鳞状上皮内病变既往称为宫颈上皮内瘤变,世界卫生组织于2014年对女性生殖器肿瘤采用了低级别和高级别两类宫颈鳞状上皮内低病变二级分类的方法;ICD-10中宫颈鳞状上皮内病变是按既往病理学分类为3级:CINⅠ,CINⅡ,CINⅢ。本文通过介绍宫颈鳞状上皮内病变的定义与分级,分别列举出ICD-10与ICD-11中的编码,结合当前的病理学诊断发展,笔者认为应将ICD-10中CINⅠ分类到宫颈的良性肿瘤,将CINⅡ,CINⅢ分类到宫颈的原位癌,同时建议病理专家在书写低级别和高级别两类宫颈鳞状上皮内低病变的病理诊断时,标注“CIN”名称和分级,为编码员在日常工作中准确编码提供参考。
Cervical squamous intraepithelial lesions were previously known as cervical intraepithelial neoplasia,and in 2014 the World Health Organization has adopted the secondary classification method of low-level and high-level cervical squamous intraepithelial lesions for female genital tumors.In ICD-10,cervical squamous intraepithelial lesions were classified into three grades according to previous pathology:CINⅠ,CINⅡ and CINⅢ.In this paper,the definition and classification of cervical squamous intraepithelial lesions are introduced,and the codes in ICD-10 and ICD-11 are listed respectively.Combined with the current pathological diagnosis development,the author believes that CINⅠ in ICD-10 should be classified into benign tumors of the cervix and that CINⅡ and CINⅢ should be classified into carcinoma in situ of the cervix.At the same time,it is suggested that pathologists should mark the name and classification of‘CIN’when writing pathological diagnosis of low-level and high-level cervical squamous intraepithelial lesions to provide reference for coders to accurately code in daily work.
作者
庞辉
刘骏峰
PANG Hui;LIU Junfeng(Department of Medical Records Management,the First Affiliated Hospital of Sun Yat-sen University,Guangzhou 510080,China)
出处
《现代医院》
2022年第4期567-569,572,共4页
Modern Hospitals
